Timetable I status surely increases the volume of complexity for almost any study review. As an example, all scientists—regardless of whether preclinical or scientific—ought to get Schedule I analysis registrations. 21 CFR section 1301.18. By contrast, scientists which have DEA Practitioner registrations in Schedules II–V (which most doctors